Putnam Investments’s Sight Sciences SGHT Stock Holding History

Putnam Investments’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,323	Closed	-$327K	–	1210
2022 Q1	$327K	Buy	+28,323	New	+$436K	﹤0.01%	1109

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Putnam Investments's SGHT Position: Q2 2022 in Review

Putnam Investments sold out of Sight Sciences (SGHT) in Q2 2022, closing a stake of 28,323 shares — an estimated $327K sold.

Putnam Investments first reported a position in SGHT in Q1 2022 and held it in 1 quarter. The position peaked at $327K in Q1 2022. 68 funds tracked by Wall St. Rank hold SGHT as of Q2 2022.

Putnam Investments reported no remaining Sight Sciences position as of Q2 2022 after selling out during the quarter.
Putnam Investments sold 28,323 Sight Sciences shares in Q2 2022, an estimated $327K.
Putnam Investments first reported a position in Sight Sciences in Q1 2022 and held it in 1 quarter.
Putnam Investments's Sight Sciences position peaked at $327K in Q1 2022.
68 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.